[Beta-blockers in portal hypertension: Unexpected limitations!]

Presse Med. 2011 Mar;40(3):227-9. doi: 10.1016/j.lpm.2010.10.003. Epub 2010 Nov 18.

[Article in French]

Authors

Thierry Thevenot, Jean-Paul Cervoni, Vincent Di Martino

PMID: 21093210
DOI: 10.1016/j.lpm.2010.10.003

No abstract available

Publication types

Editorial

MeSH terms

Adrenergic beta-Antagonists / adverse effects*
Adrenergic beta-Antagonists / therapeutic use*
Cause of Death
Esophageal and Gastric Varices / drug therapy
Esophageal and Gastric Varices / mortality
Esophagoscopy
Gastrointestinal Hemorrhage / mortality
Gastrointestinal Hemorrhage / prevention & control
Humans
Hypertension, Portal / drug therapy*
Hypertension, Portal / mortality
Ligation
Liver Cirrhosis / complications
Liver Cirrhosis / mortality
Liver Neoplasms / complications
Liver Neoplasms / mortality
Multivariate Analysis
Propranolol / adverse effects*
Propranolol / therapeutic use*
Risk Factors
Rupture, Spontaneous
Secondary Prevention
Survival Rate

Substances

Adrenergic beta-Antagonists
Propranolol